Research & Education

Evolution of Small Cell Lung Cancer Therapy: Chemotherapy and Beyond

December 6, 2017 at 9:00 P.M. EST - Recording Available

This program will provide an update of current standards of therapy for first- and second line treatment of extensive-stage small cell lung cancer (SCLC).

Management of Stage III Non-Small Lung Cancer

Monday, December 4, 2017 1:00PM EST / 11:00AM MST/ 7:00PM CET - Recording Available

This program will examine current treatment standards for stage III non-small cell lung cancer (NSCLC).

ASTRO 2017: Lung Cancer Highlights

Wednesday November 15, 2017 12:00PM EST / 10:00AM MDT / 6:00PM CET - Recording Available

This webinar will review selected presentations made at the 2017 ASTRO Annual Meeting that address the evolving role of radiation therapy in the treatment of lung malignancies.

IASLC Atlas of PD-L1 Testing in Lung Cancer

Thursday, November 9, 2017 at 9:00PM EST - Recording Available

The IASLC Atlas of PD-L1 Immunohistochemistry Testing in Lung Cancer is a new resource for understanding programmed cell death ligand-1 (PD-L1) immunohistochemistry (IHC) assays.

NSCLC Pathology and Molecular Testing - What Should Clinicians Know?

October 10, 2017 at 9:00PM EDT - Recording Available

Classification of NSCLC has been rapidly evolving, owing in large part to increased attention to histologic features and common molecular alterations.

ESMO 2017: Lung Cancer Highlights

October 9, 2017 at 7:00PM CEST - Recording Available

This webinar will highlight advances in the management of lung cancer reported during the recent European Society for Medical Oncology Congress ( ESMO 2017).

IASLC Atlas of ALK and ROS1 Testing in Lung Cancer

September 21, 2017 at 1:00 PM EST; September 21, 2017 at 6:00 PM EST - Recording Available

These live webinars are intended to help pathologists, scientists and physicians better understand the background, protocol and interpretation of results of ALK and ROS1 testing for NSCLC patients.

Three Optima for ALK Positive Lung Cancer

September 21, 2017 at 6:00PM HKT - Recording Available

This program will provide an updated view of the optimal management of ALK Positive Lung Cancer.

Radiotherapy Options in Patients with Brain Metastases from NSCLC

September 15, 2017 at 7:00PM CEST - Recording Available

In this webinar will discuss the optimal management of patients affected with brain metastases from non-small cell lung cancer (NSCLC).

Screening for Lung Cancer - What Clinicians Need to Know

September 6, 2017 at 9:00PM EDT - Recording Available

The National Lung Screening Trial provided clear evidence of a lung cancer mortality reduction in high-risk patients who undergo screening with low-dose CT.

Pages